Q32 Bio (QTTB) Cash from Financing Activities (2017 - 2026)
Q32 Bio's quarterly Cash from Financing Activities came in at $8.8 million in Q1 2026, up 663.19% quarter-over-quarter from -$1.6 million in Q4 2025.
Q32 Bio has reported Cash from Financing Activities for 10 years, with the latest figure at $8.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to $8.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (changed N/A YoY), and the FY2025 full-year result was -$3.1 million, down 103.28% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $8.8 million, up from -$1.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $99.3 million in Q1 2024, with the low at -$5.5 million in Q2 2024.
- Average Cash from Financing Activities over 5 years is $7.3 million, with a median of $100000.0 recorded in 2022.
- Peak annual rise in Cash from Financing Activities reached 662206.67% in 2024, while the deepest fall reached 36913.33% in 2024.
- Tracing QTTB's Cash from Financing Activities over 5 years: stood at $32000.0 in 2022, then soared by 137.5% to $76000.0 in 2023, then soared by 317.11% to $317000.0 in 2024, then slumped by 592.74% to -$1.6 million in 2025, then jumped by 663.19% to $8.8 million in 2026.
- The last three Cash from Financing Activities figures came in at $8.8 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 8.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.80 Mn |
| Mar 31, 2026 | 8.80 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Sep 30, 2025 | -1.56 Mn |
| Sep 30, 2025 | -1.56 Mn |
| Dec 31, 2024 | 317,000.00 |
| Dec 31, 2024 | 317,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Jun 30, 2024 | -5.52 Mn |
| Jun 30, 2024 | -5.52 Mn |
| Mar 31, 2024 | 99.35 Mn |
| Mar 31, 2024 | 99.35 Mn |
| Dec 31, 2023 | 76,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Mar 31, 2022 | 440,000.00 |
| Mar 31, 2022 | 440,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 379,000.00 |
| Sep 30, 2021 | 379,000.00 |
| Jun 30, 2021 | 49.75 Mn |
| Jun 30, 2021 | 49.75 Mn |
| Mar 31, 2021 | 2.04 Mn |
| Mar 31, 2021 | 2.04 Mn |
| Dec 31, 2020 | 52.00 Mn |
| Dec 31, 2020 | 52.00 Mn |
| Sep 30, 2020 | 410,000.00 |
| Sep 30, 2020 | 410,000.00 |
| Jun 30, 2020 | 241,000.00 |
| Jun 30, 2020 | 241,000.00 |
| Mar 31, 2020 | 447,000.00 |
| Mar 31, 2020 | 447,000.00 |
| Dec 31, 2019 | 22.58 Mn |
| Dec 31, 2019 | 22.58 Mn |
| Sep 30, 2019 | 614,000.00 |
| Sep 30, 2019 | 614,000.00 |
| Jun 30, 2019 | 134.70 Mn |
| Jun 30, 2019 | 134.70 Mn |
| Mar 31, 2019 | 325,000.00 |
| Mar 31, 2019 | 325,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Dec 31, 2018 | 41,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 151.89 Mn |
| Jun 30, 2018 | 151.89 Mn |
| Mar 31, 2018 | -958,000.00 |
| Mar 31, 2018 | -958,000.00 |
| Dec 31, 2017 | 11.66 Mn |
| Dec 31, 2017 | 11.66 Mn |
| Sep 30, 2017 | 83.09 Mn |
| Sep 30, 2017 | 83.09 Mn |
| Mar 31, 2017 | 20.48 Mn |
| Mar 31, 2017 | 20.48 Mn |